Production (Stage)
Oragenics, Inc.
OGEN
$4.28
$0.7521.25%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 7.50K | 20.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 7.50K | 20.70K |
| Cost of Revenue | 3.79M | 4.11M | 13.49M | 13.38M | 14.48M |
| Gross Profit | -3.79M | -4.11M | -13.49M | -13.37M | -14.46M |
| SG&A Expenses | 6.33M | 6.44M | 6.51M | 6.28M | 6.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.12M | 10.56M | 20.00M | 19.66M | 20.48M |
| Operating Income | -10.12M | -10.56M | -20.00M | -19.66M | -20.46M |
| Income Before Tax | -10.33M | -10.57M | -19.97M | -19.52M | -20.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.33 | -10.57 | -19.97 | -19.52 | -20.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.33M | -10.57M | -19.97M | -19.52M | -20.26M |
| EBIT | -10.12M | -10.56M | -20.00M | -19.66M | -20.46M |
| EBITDA | -8.08M | -10.53M | -19.98M | -19.64M | -20.44M |
| EPS Basic | -38.67 | -56.06 | -195.31 | -209.62 | -239.55 |
| Normalized Basic EPS | -24.17 | -35.03 | -122.07 | -131.01 | -149.72 |
| EPS Diluted | -38.67 | -56.06 | -195.31 | -209.62 | -239.55 |
| Normalized Diluted EPS | -24.17 | -35.03 | -122.07 | -131.01 | -149.72 |
| Average Basic Shares Outstanding | 1.37M | 882.30K | 571.40K | 432.30K | 348.80K |
| Average Diluted Shares Outstanding | 1.37M | 882.30K | 571.40K | 432.30K | 348.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |